Results 81 to 90 of about 12,460 (245)

Kidney stones? It's time to rethink those meds [PDF]

open access: yes, 2016
Kidney stones? It's time to rethink those meds. Despite being recommended for ureteral stone expulsion, tamsulosin or nifedipine are no more effective than placebo.
Jarrett, Jennie B.   +2 more
core  

Preparation and evaluation of tamsulosin hydrochloride sustained-release pellets modified by two-layered membrane techniques [PDF]

open access: yes, 2015
The aim of the present study was to develop tamsulosin hydrochloride sustained-release pellets using two-layered membrane techniques. Centrifugal granulator and fluidized-bed coater were employed to prepare drug-loaded pellets and to employ two-layered ...
Fan, Rui   +7 more
core   +2 more sources

Novel Coronavirus (2019-nCoV) in Disguise [PDF]

open access: yes, 2020
Novel coronavirus (2019-nCoV) pandemic is currently one of the most influential topics as it not only impacts the field of medicine but most importantly, it affects the lives of many individuals throughout the world.
Abideen, Zain U.   +4 more
core   +2 more sources

Tamsulosin induced diarrhea: a case report [PDF]

open access: yesTherapeutic Advances in Drug Safety, 2017
Tamsulosin is a uroselective α1A adrenergic receptor blocker used for benign prostatic hyperplasia with lower urinary tract symptoms.1 Other α1 blockers (nonselective subtypes) include prazosin, terazosin, and doxazocin. As per one large-scale study, dizziness, abnormal ejaculation, headache, hypotension, gastrointestinal disorder, nausea ...
Sameer Shah   +5 more
openaire   +3 more sources

Nonneurogenic female bladder outlet obstruction: Conservative and medical management

open access: yesNeurourology and Urodynamics, Volume 44, Issue 1, Page 37-43, January 2025.
Abstract Introduction In nonneurogenic female bladder outlet obstruction (BOO), management goals include reduction of outlet resistance to increase urinary outflow and improve bladder voiding to prevent or reduce lower and upper urinary tract (LUT and UUT) function deterioration, by correcting the underlying etiology.
Andry Perrin, Jacques Corcos
wiley   +1 more source

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy

open access: yesThe Prostate, Volume 85, Issue 1, Page 65-72, January 2025.
Abstract Background The medication used to treat benign prostate hyperplasia (BPH), a common condition in men over 50 years of age, can alter the levels of biomarkers used in prostate cancer detection. Commonly used medications for BPH include alpha‐blockers, 5‐alpha reductase inhibitors (5‐ARIs), and muscarinic antagonists.
Michal Jirásko   +7 more
wiley   +1 more source

Drugs help pass more ureteral stones [PDF]

open access: yes, 2008
Prescribe tamsulosin (typically 0.4 mg daily) or nifedipine (typically 30 mg daily) for patients with lower ureteral calculi, to speed stone passage and to avoid surgical intervention.
Ewigman, Bernard   +2 more
core  

The use of a percutaneous cystostomy tube as an adjunctive treatment option for dogs with idiopathic functional outflow tract obstruction

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 1, January/February 2025.
Abstract Background Functional outflow tract obstruction (FOO) remains a challenging disease to manage in male dogs. Cystostomy tubes have been used to relieve urethral obstruction while allowing time to achieve effective medical management, avoiding the need for emergency visits and repeat urinary catheterizations.
Zoe P. Greenfield   +2 more
wiley   +1 more source

Thyroid‐Stimulating Hormone‐Secreting Pituitary Adenoma: Two Cases With Challenging Diagnosis and Management

open access: yesCase Reports in Endocrinology, Volume 2025, Issue 1, 2025.
Background: Thyroid‐stimulating hormone (TSH)‐secreting pituitary adenomas (TSHomas) are very rare pituitary tumors causing central hyperthyroidism. Most are macroadenomas (≥ 10 mm) with local and systemic comorbidities at diagnosis. The atypical changes in thyroid function tests (TFTs) may be subtle and are often initially missed, while over‐secretion
Elodie Gruneisen   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy